PRKAB1

Across TCGA pan-cancer cohorts, PRKAB1 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated PRKAB1 data layer compared with 21 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher PRKAB1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated PRKAB1 expression acts as an unfavorable survival marker.

COAD, KIRC, and CESC are the cancer types where PRKAB1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.159	0.799	.005	18	view →
KIRC	OS	Median	All	0.141	0.655	.026	12	view →
CESC	DFS	Median	II,III,IV	0.193	0.705	.045	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
BLCA	OS	Median	IV	0.193	0.598	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

PRKAB1–COAD (OS)

Open the COAD breakdown →